![Stephen Rubino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Rubino
Vorstandsvorsitzender bei
Sporos Bioventures, Inc.
Profil
Stephen Rubino is currently the President, Chief Executive Officer & Director at Sporos Bioventures LLC and a Director at Sermonix Pharmaceuticals LLC.
He previously served as a Director at ILKOS THERAPEUTICS, Inc. from 2017 to 2020, an Independent Director at Viracta Therapeutics, Inc. from 2021 to 2024, the Head-Global Solid Tumor at Schering-Plough Europe SA from 1991 to 2001, and the Global Head-Business Development at Novartis Pharmaceuticals Corp.
from 2001 to 2017.
He also held the position of Chief Business Officer at Celyad Oncology SA from 2020 to 2022 and Chief Business & Strategy Officer at Omega Therapeutics, Inc. from 2018 to 2019.
Dr. Rubino holds an MBA from Baruch College and a doctorate from Weill Cornell Medical College.
Aktive Positionen von Stephen Rubino
| Unternehmen | Position | Beginn |
|---|---|---|
Sermonix Pharmaceuticals LLC
 Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Stephen Rubino
| Unternehmen | Position | Ende |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.10.2024 |
| CELYAD ONCOLOGY SA | Corporate Officer/Principal | 01.04.2022 |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Direktor/Vorstandsmitglied | 01.02.2020 |
| OMEA THER | Corporate Officer/Principal | 01.05.2019 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Stephen Rubino
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Schering-Plough Europe SA | |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sermonix Pharmaceuticals LLC
Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
